Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease [Phase 2]
Phase 2 trial assessing long-term efficacy, safety, and tolerability of repeated upadacitinib (ABT-494) in Crohn's disease; results posted a…
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: Study of ExoFlo for the Treatment of Perianal Fistulas [Phase 1, Phase 2]
Phase 1/2 study evaluating ExoFlo for perianal fistulas in Crohn's disease; trial has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 clinical trial results evaluating ustekinumab in pediatric patients with moderately to severely active Crohn's disease have been com…
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease [Phase 2]
Phase 2 clinical trial results for PDA001 in adults with moderate-to-severe Crohn's disease have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]
A clinical trial evaluating oral etrasimod for moderately to severely active Crohn's disease has completed phases 2 and 3 with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: ENhanced Recovery in CHildren Undergoing Surgery [Phase 3]
Phase 3 trial results for enhanced recovery in children undergoing surgery for inflammatory bowel disease, including Crohn's disease and ulc…
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]
A randomized active and placebo-controlled study of brazikumab in moderately to severely active Crohn's disease was terminated; results have…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]
Phase 2 trial results for rifaximin in diabetic gastroparesis are reported (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients [Phase 3]
Phase 3 clinical trial update evaluating guselkumab for Crohn's disease, focusing on transmural healing and potential disease-modifying effe…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease [Phase 3]
Phase 3 trial updating the study of guselkumab in participants with fistulizing perianal Crohn's disease; status is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension study of ustekinumab in pediatric participants (Phase 3) for Crohn disease, ulcerative colitis, and related psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 induction study investigating the efficacy and safety of Duvakitug in moderately to severely active Crohn's disease is currently rec…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety [Phase 4]
Phase 4 trial evaluating efficacy and safety of an interleukin-23 monoclonal antibody for inflammatory bowel disease is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease. [Phase 2]
A Phase 2 clinical trial evaluating whether fluconazole affects ASCA antibody levels after Crohn's disease surgical resection has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
This completed clinical trial evaluated physical fitness levels in children and adolescents with chronic inflammatory bowel disease, includi…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe [NA]
Massachusetts General Hospital reports an ongoing clinical trial using a colonoscope-compatible thermal probe to measure gut temperature in …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating mesenchymal stem cell therapy for ileal pouch fistulas in Crohn's disease participants has been termin…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease [Phase 1]
Phase 1 pediatric trial using mesenchymal stem cells to treat perianal fistulas in Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stem cell therapy for medically refractory Crohn's colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 trial evaluating mesenchymal stem cells for rectovaginal fistulas in Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating mesenchymal stem cells for perianal fistulizing Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease [Phase 1, Phase 2]
Clinical trial update indicates that the Ossium Mesenchymal Stem Cells study for pouch fistulas in Crohn's disease (Phase 1/Phase 2) has bee…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 pediatric trial is evaluating the efficacy, safety, and pharmacokinetics of Upadacitinib in moderately to severely active Crohn's …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease. [Phase 1]
Phase 1 PET imaging study update examining changes in uptake of the radiotracer [11C]AZ14132516 after administering AZD7798 in patients with…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Loss of RESponse to Ustekinumab Treated by Dose Escalation [Phase 3]
Phase 3 clinical trial update on patients with Crohn's disease showing loss of response to ustekinumab was addressed by dose escalation; res…